Intra-Individual Assessment of the Bolus Properties of 0.5M Gadopentetate Dimeglumine and 1.0M Gadobutrol in Time-Resolved Contrast-Enhanced 4D-MRA and Dynamic CT in a Minipig Model

Liver Perfusion Quantification with MR-DCE Imaging at 3.0 T for Liver Fibrosis Assessment in Patients with Chronic Liver Diseases

Risk Factors for Immediate Adverse Events to Gadolinium-Based Contrast Agents (GBCA)

The Impact of Dixon Fat Suppression on Liver T1 and DCE Perfusion Quantification